Income investors tend to gravitate towards covered calls, and blue-chip high yielding stocks are a great place to start.

This healthcare giant is trading at a discounted price today.

If you are wondering whether Pfizer's current share price reflects its long term potential or lingering concerns, looking closely at what you are paying for each dollar of its business is a useful ...

Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of this ...

Pfizer (NYSE: PFE) recently reported earnings, and its payout ratio is once again over 100%. Given that the stock is paying a fairly high yield of 6.4%, which is far above the S&P 500 average of 1.2%, ...

Right now, Pfizer's dividend payout ratio is above 100%. That suggests the dividend comes with some risk, which is true.

Pfizer (PFE) looks undervalued at 8–9x forward earnings with a ~7% yield; see how Seagen, cost cuts and the pipeline could drive $36–42 upside—read now.

Scotiabank analyst Louise Chen maintained a Buy rating on Pfizer today and set a price target of $30.00. According to TipRanks, Chen is a 4-star analyst with an average return of 4.7% and a 47.94% ...

Pfizer (NYSE: PFE) got a huge boost during the coronavirus pandemic thanks to its COVID-19 vaccine. Since that point, however, investors have soured on the stock, which has lost more than half its ...

Pfizer Inc. (NYSE:PFE) is one of the best cheap stocks under $50 to buy right now. Pfizer Inc. (NYSE:PFE) and Astellas Pharma ...

Shares of Pfizer Inc. PFE rallied 1.65% to $27.05 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 1.33% to 6,740.02 and Dow ...

If I am a Pfizer Inc. (PFE) investor (I used to be, nonetheless), I should have been "elated" at PFE's recent performance against the market, while still getting rewarded with a forward yield that ...